Luisa M. Hering

University of Liverpool — United Kingdom

Medicine · Health Sciences

9h-index897citations13works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(11), COVID-19 Clinical Research Studies(5), Immunotherapy and Immune Responses(5), COVID-19 epidemiological studies(3), Animal Virus Infections Studies(3)

Publications12 total

1167 Immunological drug-drug interactions: clinical, in-vitro and ex-vivo evidence for immune checkpoint inhibitor treatment increasing the susceptibility of patients to hypersensitivity reactions
Regular and Young Investigator Award Abstracts·2024Open Access
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines
npj Vaccines·2024· 10 citedOpen Access
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Nature Communications·2023· 37 citedOpen Access
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Med·2023· 46 citedOpen Access
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
2023Open Access
Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study
2022· 6 cited
Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study
SSRN Electronic Journal·2022· 5 citedOpen Access
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
The Lancet Microbe·2021· 174 citedOpen Access
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Cell·2021· 345 citedOpen Access
T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study
SSRN Electronic Journal·2021· 51 citedOpen Access
Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine
SSRN Electronic Journal·2021· 31 citedOpen Access
T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study
SSRN Electronic Journal·2021· 18 citedOpen Access

Frequent Co-authors

Adrienn Angyal(11), Alexander R. Nicols(11), Jessica K. Tyerman(11), Hailey Hornsby(11), Eleanor Barnes(11), C.J. Duncan(11), Miles W. Carroll(11), Lance Turtle(11), Shona C. Moore(10), Tom Tipton(10), Sarah Rowland‐Jones(10), Susan Hopkins(10), Victoria Hall(10), Thushan I. de Silva(10), Paul Klenerman(10), Susanna Dunachie(10), Naomi Meardon(9), Adrian Shields(9), Katie Jeffery(9), Anthony Brown(9)